Barclays Capital Gives Underweight Rating to Centrica (CNA)
Centrica (LON: CNA)‘s stock had its “underweight” rating reiterated by equities research analysts at Barclays Capital in a research note issued to investors on Tuesday. They currently have a $4.92 (305 GBX) price target on the stock.
A number of other firms have also recently commented on CNA. Analysts at RBC Capital reiterated a “sector perform” rating on shares of Centrica in a research note to investors on Friday. They now have a $5.00 price target on the stock. Finally, analysts at AlphaValue reiterated an “add” rating on shares of Centrica in a research note to investors on Thursday, August 23rd. They now have a $5.84 price target on the stock.
Shares of Centrica opened at 331.00 on Tuesday. Centrica has a 52 week low of GBX 248.40 and a 52 week high of GBX 336.70. The company’s market cap is £17.126 billion.
Centrica plc is an integrated energy company. The Company operates in four segments: Downstream UK, Upstream UK, Storage UK and North America.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.